Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 193

1.

Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder.

Yamamura T, Kleiter I, Fujihara K, Palace J, Greenberg B, Zakrzewska-Pniewska B, Patti F, Tsai CP, Saiz A, Yamazaki H, Kawata Y, Wright P, De Seze J.

N Engl J Med. 2019 Nov 28;381(22):2114-2124. doi: 10.1056/NEJMoa1901747.

PMID:
31774956
2.

Patterns of regional brain volume loss in multiple sclerosis: a cluster analysis.

Fujimori J, Fujihara K, Ogawa R, Baba T, Wattjes M, Nakashima I.

J Neurol. 2019 Oct 25. doi: 10.1007/s00415-019-09595-4. [Epub ahead of print]

PMID:
31654116
3.

Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial.

Cree BAC, Bennett JL, Kim HJ, Weinshenker BG, Pittock SJ, Wingerchuk DM, Fujihara K, Paul F, Cutter GR, Marignier R, Green AJ, Aktas O, Hartung HP, Lublin FD, Drappa J, Barron G, Madani S, Ratchford JN, She D, Cimbora D, Katz E; N-MOmentum study investigators.

Lancet. 2019 Oct 12;394(10206):1352-1363. doi: 10.1016/S0140-6736(19)31817-3. Epub 2019 Sep 5.

PMID:
31495497
4.

Long-term outcome of a group of Japanese children with myelin-oligodendrocyte glycoprotein encephalomyelitis without preventive immunosuppressive therapy.

Hino-Fukuyo N, Haginoya K, Takahashi T, Nakashima I, Fujihara K, Takai Y, Akasaka M, Kure S.

Brain Dev. 2019 Oct;41(9):790-795. doi: 10.1016/j.braindev.2019.06.004. Epub 2019 Jul 4.

PMID:
31281008
5.

Two Japanese cases of anti-MOG antibody-associated encephalitis that mimicked neuro-Behçet's disease.

Fujimori J, Takahashi T, Matsumoto Y, Fujihara K, Takai Y, Misu T, Nakashima I.

J Neuroimmunol. 2019 Sep 15;334:577002. doi: 10.1016/j.jneuroim.2019.577002. Epub 2019 Jun 29.

PMID:
31279093
6.

[Current Status and Prospects of Complement-Targeting Therapy for Neuromyelitis Optica].

Kuroda H, Fujihara K.

Brain Nerve. 2019 Jun;71(6):573-580. doi: 10.11477/mf.1416201318. Review. Japanese.

PMID:
31171754
7.

Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder.

Pittock SJ, Berthele A, Fujihara K, Kim HJ, Levy M, Palace J, Nakashima I, Terzi M, Totolyan N, Viswanathan S, Wang KC, Pace A, Fujita KP, Armstrong R, Wingerchuk DM.

N Engl J Med. 2019 Aug 15;381(7):614-625. doi: 10.1056/NEJMoa1900866. Epub 2019 May 3.

PMID:
31050279
8.

Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders.

Palace J, Lin DY, Zeng D, Majed M, Elsone L, Hamid S, Messina S, Misu T, Sagen J, Whittam D, Takai Y, Leite MI, Weinshenker B, Cabre P, Jacob A, Nakashima I, Fujihara K, Pittock SJ.

Brain. 2019 May 1;142(5):1310-1323. doi: 10.1093/brain/awz054.

9.

Neuromyelitis optica spectrum disorders: still evolving and broadening.

Fujihara K.

Curr Opin Neurol. 2019 Jun;32(3):385-394. doi: 10.1097/WCO.0000000000000694.

10.

Circulating AQP4-specific auto-antibodies alone can induce neuromyelitis optica spectrum disorder in the rat.

Hillebrand S, Schanda K, Nigritinou M, Tsymala I, Böhm D, Peschl P, Takai Y, Fujihara K, Nakashima I, Misu T, Reindl M, Lassmann H, Bradl M.

Acta Neuropathol. 2019 Mar;137(3):467-485. doi: 10.1007/s00401-018-1950-8. Epub 2018 Dec 18.

11.

Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations.

Juryńczyk M, Jacob A, Fujihara K, Palace J.

Pract Neurol. 2019 Jun;19(3):187-195. doi: 10.1136/practneurol-2017-001787. Epub 2018 Dec 8. Review.

PMID:
30530724
12.

Area postrema syndrome: Frequency, criteria, and severity in AQP4-IgG-positive NMOSD.

Shosha E, Dubey D, Palace J, Nakashima I, Jacob A, Fujihara K, Takahashi T, Whittam D, Leite MI, Misu T, Yoshiki T, Messina S, Elsone L, Majed M, Flanagan E, Gadoth A, Huebert C, Sagen J, Greenberg BM, Levy M, Banerjee A, Weinshenker B, Pittock SJ.

Neurology. 2018 Oct 23;91(17):e1642-e1651. doi: 10.1212/WNL.0000000000006392. Epub 2018 Sep 26.

13.

CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications.

Kaneko K, Sato DK, Nakashima I, Ogawa R, Akaishi T, Takai Y, Nishiyama S, Takahashi T, Misu T, Kuroda H, Tanaka S, Nomura K, Hashimoto Y, Callegaro D, Steinman L, Fujihara K, Aoki M.

J Neurol Neurosurg Psychiatry. 2018 Sep;89(9):927-936. doi: 10.1136/jnnp-2018-317969. Epub 2018 Jun 6. Erratum in: J Neurol Neurosurg Psychiatry. 2019 Apr;90(4):e4.

14.

Transient Pulmonary Interstitial Lesions in Aquaporin-4-positive Neuromyelitis Optica Spectrum Disorder.

Asato Y, Kamitani T, Ootsuka K, Kuramochi M, Nakanishi K, Shimada T, Takahashi T, Misu T, Aoki M, Fujihara K, Kawabata Y.

Intern Med. 2018 Oct 15;57(20):2981-2986. doi: 10.2169/internalmedicine.0580-17. Epub 2018 May 18.

15.

Fingolimod-associated PML with mild IRIS in MS: A clinicopathologic study.

Nishiyama S, Misu T, Shishido-Hara Y, Nakamichi K, Saijo M, Takai Y, Takei K, Yamamoto N, Kuroda H, Saito R, Watanabe M, Tominaga T, Nakashima I, Fujihara K, Aoki M.

Neurol Neuroimmunol Neuroinflamm. 2017 Nov 10;5(1):e415. doi: 10.1212/NXI.0000000000000415. eCollection 2018 Jan.

16.

MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis: Lessons Learned From Neuromyelitis Optica Spectrum Disorder.

Dos Passos GR, Oliveira LM, da Costa BK, Apostolos-Pereira SL, Callegaro D, Fujihara K, Sato DK.

Front Neurol. 2018 Apr 4;9:217. doi: 10.3389/fneur.2018.00217. eCollection 2018. Review.

17.

Severe aquaporin 4-IgG-positive neuromyelitis optica with disseminated herpes zoster in a pregnant woman successfully treated with intravenous immunoglobulin.

Matsumoto Y, Tsuchiya M, Norshalena S, Kaneko C, Kubo J, Yamamoto T, Takahashi T, Fujihara K.

Mult Scler J Exp Transl Clin. 2018 Mar 9;4(1):2055217318758119. doi: 10.1177/2055217318758119. eCollection 2018 Jan-Mar.

18.

Children with myelin oligodendrocyte glycoprotein antibodies-associated disease: relation of phenotypes to central nervous system myelin maturation.

Kuroda H, Fujihara K.

Dev Med Child Neurol. 2018 Apr;60(4):339-340. doi: 10.1111/dmcn.13691. Epub 2018 Feb 6. No abstract available.

19.

Nationwide epidemiological study of neuromyelitis optica in Japan.

Miyamoto K, Fujihara K, Kira JI, Kuriyama N, Matsui M, Tamakoshi A, Kusunoki S.

J Neurol Neurosurg Psychiatry. 2018 Jun;89(6):667-668. doi: 10.1136/jnnp-2017-317321. Epub 2018 Jan 11. No abstract available.

PMID:
29326292
20.

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.

Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintoré M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA.

Lancet Neurol. 2018 Feb;17(2):162-173. doi: 10.1016/S1474-4422(17)30470-2. Epub 2017 Dec 21. Review.

PMID:
29275977

Supplemental Content

Loading ...
Support Center